-
Domestic anti-PD-1 therapy! Baiji Shenzhou Baizean ® approved: joint 2 chemotherapy programs first
Time of Update: 2021-01-27
chemotherapy programs for the treatment of first-line advanced squamous non-small cell lung cancer (NSCLC) patients. this is the third ® approved in China by Bai Ze'an and the first lung cancer adaptation. It is worth noting that, more
-
2 years later it's still remission! "K medicine" is expected to be the first line of treatment for metastatic colorectal cancer
Time of Update: 2020-12-22
in the body, specializing in DNA bug fixing. these genes mutate, errors in DNA replication cannot be repaired in time, and cancer cells are more likely to cause cancerous mutations. about 5% of patients with metastatic colorectal cancer
-
New first-line treatment for lung cancer (NSCLC)! 2 immunotherapy (Opdivo and Yervoy) are approved in Japan!
Time of Update: 2020-12-21
Nov 29, 2020 // -- Ono Pharmaceuticals and Bristol-Myers Squibb K.K., the Japanese subsidiary, recently jointly announced the anti-PD-1 therapy Opdivo (Odivo, generic name: nivolumab, Navuliyu monotherapy) and anti-CTLA-4 therapy Yer Voy (ipilimumab
-
Longyu Lilian plans to invest another 2 billion yuan to build a titanium dioxide, reduced titanium and synthetic redstone production line
Time of Update: 2020-11-12
cooperation framework agreement", is expected to invest another 2 billion yuan in Nanxian County to expand a titanium dioxide, reduced titanium and synthetic redstone production line, to achieve the comprehensive utilization of waste acid, to drive the transformation and development of enterprises.
-
Lung cancer is heavy! Long-term follow-up to the first-line treatment of Keytruda and chemotherapy
Time of Update: 2020-11-02
compared to pure chemotherapy (n-63): (1) objective remission rate (ORR:58% vs 33%) was significantly increased, and medium remission duration (DOR) was extended by more than one year (36) .3 months) vs 22.8 months) ;(2) No progression lifetime
-
Lung cancer is overweight! Mercadon Keytruda first-line treatment of PD-L1 high expression lung
Time of Update: 2020-10-06
survival outcomes in these metastasis lung cancer patients. In this study, Keytruda's long-term survival benefits as a single drug are a good example of the significant progress we've made in lung cancer, providing patients with a longer, progress
-
100% disease control rate! Keytruda immunotherapy combination 1/2 line of treatment in Asian stomach cancer patients with positive results.
Time of Update: 2020-07-19
This is the first time the Keytruda/Lenvima combination has been used as a first- or second-line therapy to achieve positive clinical outcomes in the treatment of patients with advanced stomach cancer, the researchers said in the paper.
-
CELL: Isolated strong near-line SARS-CoV-2 neutralizing antibodies from newly crowned patients
Time of Update: 2020-07-13
therefore, the results show that SARS-CoV-2 neutralizing antibodies can easily be produced from different precursor pools, suggesting that there is hope for rapid induction of protective immune response after vaccination.
-
Dislocated tail bone 1/2 gap line odd nerve section puncture block treatment will be a case of pain 1 case
Time of Update: 2020-06-22
The pain is a common disease of clinical pain physicians, with female patients as common, the ratio of men and women is about 1:3 to 1:2, of which 40 to 60 years of age patients are common, the course of the disease
-
Poxel SA's oral type 2 diabetes innovative therapy imeglimin Phase 3 clinical trial gets positive top-line results
Time of Update: 2020-06-07
today, Poxel SA company ( announced that the company's innovative oral type 2 diabetes treatment, imeglimin, has achieved positive top-line results in the Open Label Extension Research
-
Takeda Alunbrig first-line treatment nSCLC efficacy actively delays disease progression in specific patients for more than 2 years
Time of Update: 2020-06-01
The results showed that the non-progressive life span (PFS) in patients in the Alunbrig group was 29.4 months, compared with 9.2 months in the active control group.
-
Interview with the first-line doctors of the United States against epidemic s: quarantine 2 weeks
Time of Update: 2020-05-28
Texts . . . Wang Chen Professor of Respiratory and Critical Care at the University of Southern California Medical Center, and has been leading the new crown treatment at Nanga Hospital since March. Meanwhile, he was quarantined for two weeks
-
First-line treatment of liver cancer, rare diseases new drugs have been accepted 2 innovative
Time of Update: 2020-05-18
The text . . . Eva this week: three innovative therapies (two heavy-duty innovative drugs) in China were approved. Chinese medicine re-power, another new drug on the market. rare disease new drug, Roche IL-6 antibody domestic
-
First line immunotherapy for stage 4 lung cancer! AstraZeneca imfinzi 2 schemes were successful
Time of Update: 2019-10-29
October 29, 2019 / BIOON / -- AstraZeneca recently announced the positive progression free survival (PFS) results of Poseidon in the phase III clinical study of PD-L1 tumor
-
Sold 200 million in 2 months! This medicine is a first-line targeted therapy for liver cancer, Hengrui, Shiyao Made the effort.
Time of Update: 2019-06-10
Lovatinib is the first drug approved for first-line treatment of advanced liver cancer in China in recent 10 years
Since then, it has broken the monopoly of sorafenib
-
[Yao Kejun] the first-line medicine for lung cancer is imitated. Zhengda Tianqing, Haosen, Qilu
Time of Update: 2019-04-01
Focus on 1.2 collinear generic drugs to be included in the priority review, and fierce competition for consistency evaluation; 2
Entecavir children's dosage forms
-
First line treatment for type 2 diabetes also reduces the risk of heart disease in patients with type 1 diabetes
Time of Update: 2017-06-14
According to a new global trial launched by the University of Glasgow (http://www.chemdrug.com/sell/24/), low-cost first-line drugs for type 2 diabetes (http://www.chemdrug.com
-
The western development and the memory of the third line construction (2)
Time of Update: 2003-03-12
OA show ('918 '); 3
If the inevitable result of the spontaneous operation of the market is to widen the gap between the East and the west, the reasons and means
